In addition, HMA may recalibrate the immune microenvironment, via promoting anti-tumor response by upregulation of the antigen presentation pathway, TH1 and TH17 polarization, cytotoxic CD8 T-cells activation, Treg function reduction and immune checkpoint blockade (64, 86). This evidence concerns the gene CD8A and neoplasm.